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Abstract

AN ADAPTIVE DOSE FINDING DESIGN (DOSEFIND) USING A NONLINEAR
DOSE RESPONSE MODEL
By James Michael Davenport, PhD
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2007

Major Director: R. K. Elswick
Interim Department Chair, Biostatistics

First-in-man (FIM) Phase I clinical trials are part of the critical path in the development of
a new compound entity (NCE). Since FIM clinical trials are the first time that an NCE is
dosed in human subjects, the designs used in these trials are unique and geared toward
patient safety. We develop a method for obtaining the desired response using an adaptive
non-linear approach. This method is applicable for studies in which MTD, NOEL,
NOAEL, PK, PD effects or other such endpoints are evaluated to determine the desired
dose. The method has application whenever a measurable PD marker is an indicator of
potential efficacy and could be particularly useful for dose finding studies. The advantages
in the adaptive non-linear methodology is that the actual range of dose response and lowest
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non-effective dose levels are more quickly and accurately determined using fewer subjects
than typically needed for a conventional early phase clinical trial. Using the nonlinear
logistic model, we demonstrate, with simulations, that the DOSEFIND approach has better
asymptotic relative efficiency than a fixed-dose approach. Further, we demonstrate that,
on average, this method is consistent in reproducing .the target dose, that it has very little
bias. This is an indicator of reproducibility of the method, showing that the long-run
average error is quite small. Additionally, DOSEFIND is more cost effective because the
sample size needed to obtain the desired target dose is much smaller than that needed in the
fixed dose approach.

